Calcium Resonium 99.934% w/w Powder for Oral/Rectal Suspension
Last Updated on eMC 21-Jan-2014 View document | SANOFI Contact details
Versions
When a pharmaceutical company changes an SPC or PIL, a new version is published on the eMC. For each version, we show the dates it was published on the eMC and the reasons for change.
Updated on 21-Jan-2014 and displayed until Current
Reasons for adding or updating:
- Change to section 2 - what you need to know - warnings and precautions
- Change to section 2 - interactions with other medicines, food or drink
- Change to section 4 - possible side effects
- Change to section 6 - date of revision
Updated on 31-Jul-2013 and displayed until 21-Jan-2014
Reasons for adding or updating:
- Change to section 4 - how to report a side effect
Updated on 17-Sep-2012 and displayed until 31-Jul-2013
Reasons for adding or updating:
- Change to Further Information section
- Change to warnings or special precautions for use
- Change to Marketing Authorisation Holder
Updated on 08-Jul-2011 and displayed until 17-Sep-2012
Reasons for adding or updating:
- Change of trade or generic name
Updated on 08-Mar-2011 and displayed until 08-Jul-2011
Reasons for adding or updating:
- Change to Marketing Authorisation Holder
Updated on 18-Oct-2010 and displayed until 08-Mar-2011
Reasons for adding or updating:
- Change to warnings or special precautions for use
- Change to side-effects
- Change to drug interactions
Updated on 18-Aug-2010 and displayed until 18-Oct-2010
Reasons for adding or updating:
- Change to packaging
Updated on 03-Jun-2008 and displayed until 18-Aug-2010
Reasons for adding or updating:
- Change due to user-testing of patient information
Updated on 27-Jul-2006 and displayed until 03-Jun-2008
Reasons for adding or updating:
- Change to date of revision
Updated on 13-Apr-2005 and displayed until 27-Jul-2006
Reasons for adding or updating:
- Change from BAN to rINN
Updated on 22-Oct-2004 and displayed until 13-Apr-2005
Reasons for adding or updating:
- New PIL for eMC ie a PIL for an existing product but one that is new to the eMC
SANOFI
1 Onslow Street, Guildford, Surrey, GU1 4YS, UK
+44 (0)1483 535 432
+44 (0)1483 505 515
+44 (0)845 372 7101
Before you contact this company: often several companies will market medicines with the same active ingredient. Please check that this is the correct company before contacting them. Why?
Active ingredients
Legal categories
This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue